MUC1 and silicosis: This study aimed to evaluate serum Krebs von den Lungen-6 (KL-6) levels in silicosis patients across different disease stages and explore their association with immune-inflammatory markers to assess its potential as a biomarker for early diagnosis and risk stratification.